Oxford BioMedica PLC (OXB)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
308.50p
Buy
313.50p
-16.50p (-5.02%)
Oxford BioMedica PLC is a biopharmaceutical company based in the United Kingdom. It develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.
Prices updated at 28 May 2025, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
16 May 202501 May 202530 Apr 202529 Apr 202528 Apr 202523 Apr 202509 Apr 202504 Apr 202501 Apr 202527 Mar 2025
Key dates
| Forecast date | |
|---|---|
| Annual report | Apr 2026 |
| Final results | Apr 2026 |
| Half yearly results | Sep 2025 |
| Annual general meeting | Jun 2025 |
| Previous date | |
|---|---|
| Annual report | Apr 2025 |
| Final results | Apr 2025 |
| Half yearly results | Sep 2024 |
| Annual general meeting | Jun 2024 |
Company reports
31 Dec 2022
Annual Report 30 Jun 2012
Quarterly Report 